Introduction
Molecules containing oxygen or sulfur heteroatoms have undergone extensive study over the years and their chemistry heavily investigated compared to selenium.
The inimitable redox properties of selenium are influential in the catalytic and biological activities of organoselenium compounds, especially among compounds in which selenium is a part of the heterocyclic ring. However, there are several differences in organoselenium compounds despite the similarities between the molecules containing sulfur and their selenium congeners. They can be used in nucleophilic and electrophilic as well as in radical reactions.
1−3 Therefore, many syntheses of heterocyclic compounds based on selenium have been developed into standard procedures in organic chemistry. 1−3 The synthesis of heterocyclic compounds containing sulfur and selenium has been reported within the past several years because of their chemical properties, 4, 5 biological activity, and pharmaceutical potential. 6, 7 Some organoselenium compounds, for example oligoselenophenes, are known organic semiconductors, particularly in the application to thin-film transistors (TFT). 8 2-β -D-ribofuranosylselenazole-4-carboxamide was found to be effective against Lewis lung carcinoma in mice. 9 Selenium-containing bicyclic heterocycles having activity as D-amino acid oxidase (DAO) inhibitors are useful in the treatment of neurodegenerative and psychiatric disorders and diseases. 10 In addition, pyrim-idine is considered one of the most important pharmacophoric rings, exhibiting remarkable pharmacological activities since it is one of the essential building blocks of nucleic acids, DNA, and RNA. Thienopyrimidines fused heteroaromatic ring systems, however, have a special importance as they serve as structural analogues for biogeneric purines and potential nucleic acid antimetabolites.
11
In the literature, several studies have been reported on thienopyrimidine derivatives; however, studies on selenium-containing derivatives are not abundant and some of them are related to 4-(aryl amino)selenophene pyrimidine derivatives having antitumor effects on proliferative disorders, particularly cancer.
12,13
Our interest focuses in particular on the synthesis of new polyheterocyclic seven-membered cycloalkanefused selenophene derivatives and their further screening for anticancer activity.
Results and discussion

Chemistry
The synthetic pathways for all target molecules are illustrated in Schemes 1-4. 2-Amino-3-cyanoselenophene 1 was prepared from the classical, multicomponent Gewald reaction.
14−17 A mixture of metallic selenium, cycloheptanone, and malononitrile in ethanol in the presence of morpholine was refluxed and 1 was isolated in good yield.
Heating 1 with formic acid and a catalytic amount of concentrated acid gave 6, which on treatment with phosphorus oxychloride afforded 4-chloro-6,7,8,9-tetrahydro-5H -cyclohepta [4, 5] selenopheno [2,3-d] pyrimidine (3) (Scheme 1). 18 The IR spectrum of 6 indicated the presence of absorption bands at 3216 and 1652 cm −1 corresponding to NH and C=O groups, respectively. 1 H NMR spectra revealed the disappearance of signals at δ 4.97 ppm of 1, whereas appearance of the exchangeable signal at δ 12.36 ppm and one singlet at δ 7.95 ppm indicated the NH and C-2 proton of selenopyrimidine, respectively. 4-Chloroselenopyrimidine 12 showed the disappearance of signals at δ 12.36 ppm and signals at δ 7.95 ppm indicated the NH and CH protons, respectively.
Furthermore, 6,7,8,9-tetrahydro-5H-cyclohepta [4, 5] The IR spectrum of 15 showed the disappearance of the CN group absorption band of the precursor 1 at 2200 cm −1 . 1 H NMR spectra revealed the presence of the signal due to NH 2 protons in the aromatic region in addition to the singlet at δ 8.11 ppm corresponding to the pyrimidine ring CH proton.
4-Chloro-6,7,8,9-tetrahydro-5H -cyclohepta [4, 5] Nucleophilic reaction of the chloro-substituted pyrimidine derivative 12 with the appropriate amine in Et 3 N and heating under reflux led to the compounds 27 and 28 (Scheme 3). The products were isolated as colorless solids. The 1 H NMR spectra of 27 and 28 with peaks between δ 1.88 and 3.86 ppm belong to the methylenic protons.
Scheme 1. Synthesis of selenophenopyrimidinone 6 and chloroselenophenopyrimidine 12.
The structures of the synthesized compounds were determined on the basis of spectroscopic and analytical data. The IR spectra of 27 and 28 showed C-N bands at 1115-1126 cm −1 that were not present in the precursor.
In the 1 H NMR spectra of 27 and 28, which were synthesized via the substitution of the chlorine atom of 12 with pyrrolidine and morpholine, the C=NH signals showed peaks at δ 8.31, 8.82, and 8.52 ppm, respectively. In the precursor, the C=NH signals was at δ 8.66 ppm.
Scheme 2. Synthesis of 4-aminoselenophenopyrimidine 15.
Scheme 3. Synthesis of polyheterocyclic selenophenes. (12) with nucleophiles.
Anticancer activity
The compounds were evaluated at a different concentration for anticancer activity against the MCF-7 cell line. 
Synthesis of 4-chloro-6,7,8,9-tetrahydro-5H -cyclohepta[4,5]seleno[2,3-d ]pyrimidine (12)
To a stirred solution of 3,5,6,7,8,9-hexahydro-4H-cyclohepta [4, 5] selenopheno[2,3-d]pyrimidin-4-one (6) (2.67 g, 0.01 mol) in dioxane (30 mL) was added POCl 3 (7 mL) dropwise at room temperature. The mixture was refluxed for 4 h. After this time it was cooled and poured dropwise into a water-ice bath. The resulting solid was filtered off and dried in vacuo. The solid product was recrystallized with diethyl ether. 
Synthesis of 4-hydrazinyl-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]selenopheno[2,3-4 d]pyrimidine (19)
To a solution of 4-chloro-6,7,8,9-tetrahydro-5H-cyclohepta [4, 5] The reaction mixture of 4-hydrazinyl-6,7,8,9-tetrahydro-5H-cyclohepta [4, 5] selenopheno[2,3-4 d]pyrimidine (19) (0.28 g, 0.001 mol) and trimethylorthoformate (5 mL) was refluxed for 3 h. After completion, the mixture was cooled to room temperature and the solid was precipitated. The resulting solid product was filtered, washed with cold ethanol (5 mL), and recrystallized from ethanol. bovine serum and 1% penicillin-streptomycin. Cells were kept incubated in a CO 2 incubator at 37
• C under a humidified atmosphere of 5% CO 2 . The medium was replaced three times a week. For enumeration, 100 µ L of cells concentration were stained with trypan blue (0.4%) and the cells were counted using a hemocytometer.
MTT assay
MCF-7 (5 × 10 3 cells) was seeded in each well of a 96-well plate, using 100 µ L of culture media. They were allowed to attach for 24 h in a CO 2 incubator. The medium was aspirated and adherent cells were exposed to the medium containing varying concentrations of the compounds (5, 10, 25, 50, 100, and 200 µ M) for 24 h.
After exposure, 10 µ L of the solubilized MTT (stock solution of 12 mM MTT was prepared by adding 1 mL of sterile PBS to one 5-mg vial of MTT) was added to each well, and the cultures were incubated for an additional 4 h. The medium was carefully discarded. For solubilization of formazan crystals (MTT formazan), 100 µ L of dimethylsulfoxide (DMSO) was added to each well. The absorbance at 540 nm was determined in each well with a microplate reader. The growth of the treated cells was compared with that of the untreated cells and calculated using the formula: (absorbance treated wells/absorbance untreated wells) × 100. 
Conclusion
In this work, eight pyrimidone, chloropyrimidine, triazole, and tetrazol functionalized cycloalkylselenophene derivatives were prepared after several steps starting from 2-amino-5, 
